← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Sep 1, 2026

ROCKWELL MEDICAL, INC. (RMTI)

Healthcare • NASDAQ

$8.31

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

28.0/100

POOR BUSINESS

ROCKWELL MEDICAL, INC. (RMTI) scores 28/100 — concerning metrics indicating significant structural or financial risks.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full RMTI quality analysis & detailed breakdown

VALUATION SIGNAL

N/A (Requires more data)

Requires fair value calculation and current price data

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full RMTI valuation analysis · → View full RMTI Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-14.0%)

Debt-to-Equity (Solvency Risk):EXCELLENT (0.27x)

Operating Margin (Operational Efficiency):CRITICAL (-6.5%)

Return on Capital (Capital Efficiency):CRITICAL (-10.1%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

ROCKWELL MEDICAL, INC. (RMTI) stock report — Zyberno Score 28/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, RMTI generated $1.76M in Owner Earnings. Capital was deployed as follows: $904.00K invested in capital expenditures. Reinvestment rate: 48.6%.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:8.31

Market Cap:$32.90M

Valuation Multiples (3)

P/B Ratio:0.94x

P/S Ratio:0.47x

Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$31.38M

Pfcf Ratio:16.69x

Price Action & Momentum (3)

12-1 Momentum:

-52.6% (14th pctile)

📈 Click to view full RMTI Momentum analysis →

Momentum Percentile:14 / 100

% of 52-Week High:39.6%

B. Profitability Assessment

Return Metrics (5)

ROE:

-14.0%

📊 Click to view full RMTI ROE analysis →

ROA:-8.9%

Roic:

-10.1%

📊 Click to view full RMTI ROIC analysis →

Reinvestment Rate:48.6%

Fundamental Growth Rate (g):-4.9%

Margin Analysis (3)

Operating Margin Ttm:-6.5%

Net Margin Ttm:-7.3%

Ebitda Margin:-3.6%

TTM Performance (3)

Gross Margin Ttm:17.7%

Operating Margin Ttm:-6.5%

Net Margin Ttm:-7.3%

Yield Metrics (3)

Earnings Yield:-$2.02

Owner Earnings Yield:$5.99

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):

-0.04

📊 Click to view full RMTI Earnings Surprise analysis →

EPS Surprise vs Expected:-45.5%

Latest Earnings Filed:2026-05-07

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-4.2%

Cash Flow Growth (Linear) (1)

Operating Cash Flow Growth Rate (Linear):8.7%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.25x

Quick Ratio:3.00x

Cash Ratio:0.94x

Leverage Analysis (3)

Debt To Equity Ttm:0.27x

Debt-to-Equity Ratio:0.27x

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-4.14x

Times Interest Earned:-4.14

Capital Structure (4)

Working Capital:25,186,000.00

Cash And Cash Equivalents:10,519,000.00

Long Term Debt:$7.24M

Net Debt:-$1.52M

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $69.39M

Linear Growth: -4.2%

📊 Click to view full RMTI Revenue analysis & methodology →

Cost Of Revenue Ttm:$57.10M

Profitability Breakdown (2)

Gross profit TTM: $12.29M

Linear Growth: 24.9%

📊 Click to view full RMTI Gross Profit analysis & methodology →

-$4.52M

Bottom Line Performance (3)

-$5.08M

Income Before Tax:-$27.71M

Ebitda Ttm:-2,522,000.00

Operating Expenses (5)

Operating Expenses:0.00

R And D Expense:40,000.00

Sga Expense:14,558,000.00

Income Tax Expense:-$404.53K

Interest Expense:1,134,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.2%

Sga To Revenue Percentage:81.9%

Ebitda Margin:-3.6%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$56.53M

Current Assets:$36.36M

Ppe Net:4,622,000.00

Goodwill:920,000.00

Intangible Assets:$9.38M

Liability Structure (4)

Total Liabilities:21,441,000.00

Current Liabilities:11,174,000.00

Long Term Debt:$7.24M

Short Term Debt:$1.77M

Equity & Capital (3)

Equity:$35.09M

Retained Earnings:-$405.77M

Common Stock:170,000,000.00

Working Capital Items (3)

Accounts Receivable:8,305,000.00

Inventory:2,817,000.00

Accounts Payable:3,179,000.00

Special Items (2)

Contract Liabilities:0.00

Stock Based Compensation:403,000.00

C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $2.66M

Linear Growth: 8.7%

$1.76M

Investment Activities (2)

Investing Cash Flow:-$122.00K

Capital Expenditures Ttm:904,000.00

Financing Activities (3)

Financing Cash Flow:-$813.00K

Dividends Paid Ttm:0.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:7,816,000.00

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$2.00M

Non-Cash Items (1)

Depreciation Amortization Ttm:2,001,000.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.44

-$0.15

Earnings Per Share Ttm:-$1.28

Revenue & Cash Per Share (3)

Sales Per Share Ttm:17.53

Operating Cash Flow Per Share:-$0.17

Fcf Per Share Ttm:0.44

Book Value & Capital (2)

Book Value Per Share:$8.86

Cash Per Share:2.66

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.21x

Working Capital Turnover Ttm:2.76x

Receivables Management (2)

Receivables Turnover Ttm:8.36x

Days Sales Outstanding Ttm:43.69

Inventory Management (2)

Inventory Turnover Ttm:20.27x

Days Inventory Outstanding Ttm:18.01

Payables & Cash Cycle (2)

Days Payable Outstanding:20.32

Cash Conversion Cycle:41.37

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00

Quality Score:40.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $1.76M

Linear Growth: 0.0%

📊 Click to view full RMTI Owner Earnings analysis & methodology →

Owner Earnings Per Share:$0.44

Owner Earnings Yield:$5.99

Damodaran Growth Analysis (2)

Reinvestment Rate:48.6%

Fundamental Growth Rate (g):-4.9%

Return Scenarios (1)

Forward Expected Return (Yield + Growth):

1.1%

📊 Click to view full RMTI expected return analysis →

Investment Assessment (1)

Buffett Assessment:Overvalued

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-4.2%

Cash Flow Growth Rates (1)

Operating Cash Flow Growth Rate (Linear):8.7%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):24.9%

Book Value Growth Rate (Linear):31.2%

C. Company Profile & Context

Corporate Information (6)

Symbol:RMTI

Company Name:ROCKWELL MEDICAL, INC.

Sector:Healthcare

Industry:Pharmaceuticals

Exchange:NASDAQ

Country:United States

Market Classification (3)

Market Cap Category:N/A

Price Category:low

Volume Category:N/A

Share Structure (3)

Shares Outstanding:3.96M

Shares Outstanding Basic:3.96M

Shares Outstanding Diluted:3.96M

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-09-01 09:16:19 UTC

Data Timestamp:2026-08-20T23:08:30.326405